uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)
Close on Nov 18, 2026Market cap $1.41BP/E –Yield –
uniQure operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
uniQure's operating cash flow for the twelve months ending Jun 30, 2026 was -$160.79M. For fiscal 2025 it was -$177.96M. The highest annual figure on record is $287.96M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$177.96M | – |
| FY2024 | Dec 31, 2024 | -$182.73M | – |
| FY2023 | Dec 31, 2023 | -$145.93M | – |
| FY2022 | Dec 31, 2022 | -$145.06M | -150.4% |
| FY2021 | Dec 31, 2021 | $287.96M | – |
| FY2020 | Dec 31, 2020 | -$134.83M | – |
| FY2019 | Dec 31, 2019 | -$98.68M | – |
| FY2018 | Dec 31, 2018 | -$76.04M | – |
| FY2017 | Dec 31, 2017 | -$64.27M | – |
| FY2016 | Dec 31, 2016 | -$72.19M | -1066.6% |
| FY2015 | Dec 31, 2015 | $7.47M | – |
| FY2014 | Dec 31, 2014 | -$36.85M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$28.58M | – |
| Q1 FY2026 | Mar 31, 2026 | -$38.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$77.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$16.40M | – |
| Q2 FY2025 | Jun 30, 2025 | -$39.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$44.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$52.84M | – |
| Q3 FY2024 | Sep 30, 2024 | -$36.60M | -194.1% |
| Q2 FY2024 | Jun 30, 2024 | -$32.71M | – |
| Q1 FY2024 | Mar 31, 2024 | -$60.58M | – |
| Q4 FY2023 | Dec 31, 2023 | -$49.54M | – |
| Q3 FY2023 | Sep 30, 2023 | $38.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$57.00M | – |
| Q1 FY2023 | Mar 31, 2023 | -$78.30M | – |
| Q4 FY2022 | Dec 31, 2022 | -$54.68M | – |
| Q3 FY2022 | Sep 30, 2022 | -$48.99M | – |
| Q2 FY2022 | Jun 30, 2022 | -$15.68M | -103.8% |
| Q1 FY2022 | Mar 31, 2022 | -$25.71M | – |
| Q4 FY2021 | Dec 31, 2021 | -$47.09M | – |
| Q3 FY2021 | Sep 30, 2021 | -$40.16M | – |
| Q2 FY2021 | Jun 30, 2021 | $416.48M | – |
| Q1 FY2021 | Mar 31, 2021 | -$41.27M | – |
| Q4 FY2020 | Dec 31, 2020 | -$37.18M | – |
| Q3 FY2020 | Sep 30, 2020 | -$34.71M | – |
| Q2 FY2020 | Jun 30, 2020 | -$29.99M | – |
| Q1 FY2020 | Mar 31, 2020 | -$32.95M | – |
| Q4 FY2019 | Dec 31, 2019 | -$26.01M | – |
| Q3 FY2019 | Sep 30, 2019 | -$22.02M | – |
| Q2 FY2019 | Jun 30, 2019 | -$24.22M | – |
| Q1 FY2019 | Mar 31, 2019 | -$26.44M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.00M | – |
| Q3 FY2018 | Sep 30, 2018 | -$20.06M | – |
| Q2 FY2018 | Jun 30, 2018 | -$16.54M | – |
| Q1 FY2018 | Mar 31, 2018 | -$21.44M | – |
| Q4 FY2017 | Dec 31, 2017 | -$18.05M | – |
| Q3 FY2017 | Sep 30, 2017 | -$15.42M | – |
| Q2 FY2017 | Jun 30, 2017 | -$19.14M | – |
| Q1 FY2017 | Mar 31, 2017 | -$11.67M | – |
| Q4 FY2016 | Dec 31, 2016 | -$15.67M | – |
| Q3 FY2016 | Sep 30, 2016 | -$18.05M | – |
See a number that looks wrong?